Privia CEO tax-withholding sale of 26,509 shares

Privia Health Group, Inc. Chief Executive Officer Parth Mehrotra reported a sale of 26,509 shares of common stock on March 16, 2026 at an average price of $22.11 per share.

Accepted by SEC EDGAR 03/18/2026 - 04:06 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Privia Health Group, Inc. Chief Executive Officer Parth Mehrotra reported a sale of 26,509 shares of common stock on March 16, 2026 at an average price of $22.11 per share. According to the disclosure, this was a nondiscretionary sale to cover tax withholding obligations related to vesting and settlement of performance stock units. After the transaction, Mehrotra directly holds 555,443 shares of Privia Health Group common stock.

Insider Trade Summary

Net Seller: 26,509 shares

Net Sell 1 txn

Insider Mehrotra Parth

Role Chief Executive Officer

Sold 26,509 shs ($586K)

Share of Position Sold 4.6%

Type	Security	Shares	Price	Value
Sale	Common Stock, $0.01 par value per share	26,509	$22.11	$586K

Holdings After Transaction: Common Stock, $0.01 par value per share — 555,443 shares (Direct)

Holdings Before and After: Common Stock, $0.01 par value per share, 581,952 to 555,443 shares (Direct)

Other Insiders: 3 other insiders reported open-market sales of this stock in the 30 days up to this filing.

Footnotes (1)

1. F1. The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the Reporting Person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of performance stock units.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Privia Health Group (PRVA) report for Parth Mehrotra?

Privia Health Group reported that CEO Parth Mehrotra sold 26,509 shares of common stock. The sale occurred on March 16, 2026, and was tied to tax withholding obligations from vesting and settlement of performance stock units rather than a discretionary open-market trade.

At what price did Parth Mehrotra’s PRVA shares sell in the latest Form 4?

The reported sale of Privia Health Group shares by CEO Parth Mehrotra was executed at an average price of $22.11 per share. This nondiscretionary transaction was conducted to satisfy tax withholding obligations arising from the vesting and settlement of performance stock units.

How many PRVA shares does CEO Parth Mehrotra hold after this Form 4 sale?

Following the reported sale, CEO Parth Mehrotra directly holds 555,443 shares of Privia Health Group common stock. This reflects his remaining ownership after 26,509 shares were sold to cover tax withholding obligations connected to the vesting and settlement of performance stock units.

Was the PRVA insider sale by Parth Mehrotra a discretionary open-market transaction?

The filing states the sale was a nondiscretionary transaction required to cover tax withholding obligations. It was linked to the vesting and settlement of performance stock units, meaning the sale was driven by tax requirements rather than a voluntary open-market decision to reduce holdings.

What type of equity award triggered the PRVA tax-withholding sale for Parth Mehrotra?

The nondiscretionary sale was connected to performance stock units. The filing explains that shares were required to be sold to satisfy tax withholding obligations arising from the vesting and settlement of these performance-based equity awards held by CEO Parth Mehrotra.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mehrotra Parth

(Last) (First) (Middle)

PRIVIA HEALTH GROUP, INC.

950 N. GLEBE RD., SUITE 700

(Street)

ARLINGTON VIRGINIA 22203

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Privia Health Group, Inc. [ PRVA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $0.01 par value per share	03/16/2026		S(1)		26,509	D	$22.11	555,443	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the Reporting Person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of performance stock units.

Remarks:

	/s/ Anita Beth Adams, as attorney-in-fact	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)